Metformin in non-Diabetic Patients Presenting with ST Elevation Myocardial Infarction: Rationale and Design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction (GIPS)-III Trial

C.P.H. Lexis; I.C.C. van der Horst; E. Lipsic; P. van der Harst; A. van der Horst-Schrivers; B.H.R. Wolffenbuttel; R.A. de Boer; A.C. van Rossum; D.J. van Veldhuisen; B.J.G.L. De Smet

doi:10.1007/s10557-012-6413-1

Metformin in non-Diabetic Patients Presenting with ST Elevation Myocardial Infarction: Rationale and Design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction (GIPS)-III Trial

C.P.H. Lexis, I.C.C. van der Horst, E. Lipsic, P. van der Harst, A. van der Horst-Schrivers, B.H.R. Wolffenbuttel, R.A. de Boer, A.C. van Rossum, D.J. van Veldhuisen, B.J.G.L. De Smet

Cardiology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	417-426
Journal	Cardiovascular Drugs and Therapy
Volume	26
Issue number	5
DOIs	https://doi.org/10.1007/s10557-012-6413-1
Publication status	Published - 2012

Access to Document

10.1007/s10557-012-6413-1

Cite this

Lexis, C. P. H., van der Horst, I. C. C., Lipsic, E., van der Harst, P., van der Horst-Schrivers, A., Wolffenbuttel, B. H. R., de Boer, R. A., van Rossum, A. C., van Veldhuisen, D. J., & De Smet, B. J. G. L. (2012). Metformin in non-Diabetic Patients Presenting with ST Elevation Myocardial Infarction: Rationale and Design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction (GIPS)-III Trial. Cardiovascular Drugs and Therapy, 26(5), 417-426. https://doi.org/10.1007/s10557-012-6413-1

Lexis, C.P.H. ; van der Horst, I.C.C. ; Lipsic, E. et al. / Metformin in non-Diabetic Patients Presenting with ST Elevation Myocardial Infarction: Rationale and Design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction (GIPS)-III Trial. In: Cardiovascular Drugs and Therapy. 2012 ; Vol. 26, No. 5. pp. 417-426.

@article{bca0e13c452c414db23ba3e8d97a2550,

title = "Metformin in non-Diabetic Patients Presenting with ST Elevation Myocardial Infarction: Rationale and Design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction (GIPS)-III Trial",

author = "C.P.H. Lexis and {van der Horst}, I.C.C. and E. Lipsic and {van der Harst}, P. and {van der Horst-Schrivers}, A. and B.H.R. Wolffenbuttel and {de Boer}, R.A. and {van Rossum}, A.C. and {van Veldhuisen}, D.J. and {De Smet}, B.J.G.L.",

year = "2012",

doi = "10.1007/s10557-012-6413-1",

language = "Undefined/Unknown",

volume = "26",

pages = "417--426",

journal = "Cardiovascular Drugs and Therapy",

issn = "0920-3206",

publisher = "Kluwer Academic Publishers",

number = "5",

}

Lexis, CPH, van der Horst, ICC, Lipsic, E, van der Harst, P, van der Horst-Schrivers, A, Wolffenbuttel, BHR, de Boer, RA, van Rossum, AC, van Veldhuisen, DJ & De Smet, BJGL 2012, 'Metformin in non-Diabetic Patients Presenting with ST Elevation Myocardial Infarction: Rationale and Design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction (GIPS)-III Trial', Cardiovascular Drugs and Therapy, vol. 26, no. 5, pp. 417-426. https://doi.org/10.1007/s10557-012-6413-1

Metformin in non-Diabetic Patients Presenting with ST Elevation Myocardial Infarction: Rationale and Design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction (GIPS)-III Trial. / Lexis, C.P.H.; van der Horst, I.C.C.; Lipsic, E. et al.

In: Cardiovascular Drugs and Therapy, Vol. 26, No. 5, 2012, p. 417-426.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Metformin in non-Diabetic Patients Presenting with ST Elevation Myocardial Infarction: Rationale and Design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction (GIPS)-III Trial

AU - Lexis, C.P.H.

AU - van der Horst, I.C.C.

AU - Lipsic, E.

AU - van der Harst, P.

AU - van der Horst-Schrivers, A.

AU - Wolffenbuttel, B.H.R.

AU - de Boer, R.A.

AU - van Rossum, A.C.

AU - van Veldhuisen, D.J.

AU - De Smet, B.J.G.L.

PY - 2012

Y1 - 2012

U2 - 10.1007/s10557-012-6413-1

DO - 10.1007/s10557-012-6413-1

M3 - Article

C2 - 22968678

VL - 26

SP - 417

EP - 426

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

SN - 0920-3206

IS - 5

ER -

Lexis CPH, van der Horst ICC, Lipsic E, van der Harst P, van der Horst-Schrivers A, Wolffenbuttel BHR et al. Metformin in non-Diabetic Patients Presenting with ST Elevation Myocardial Infarction: Rationale and Design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction (GIPS)-III Trial. Cardiovascular Drugs and Therapy. 2012;26(5):417-426. doi: 10.1007/s10557-012-6413-1